Eren, F. Et Al. 2012. Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease. Clinical Biochemistry , vol.45 , 655-658.

Eren, F., Kurt, R., Ermis, F., Atuğ, Ö., Imeryuz, N., & Yılmaz, Y., (2012). Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease. Clinical Biochemistry , vol.45, 655-658.

Eren, Fatih Et Al. "Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease," Clinical Biochemistry , vol.45, 655-658, 2012

Eren, Fatih Et Al. "Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease." Clinical Biochemistry , vol.45, pp.655-658, 2012

Eren, F. Et Al. (2012) . "Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease." Clinical Biochemistry , vol.45, pp.655-658.

@article{article, author={Fatih Eren Et Al. }, title={Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease}, journal={Clinical Biochemistry}, year=2012, pages={655-658} }